Picture of ADBiotech Co logo

179530 ADBiotech Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-9.75%
3m-19.43%
6m-24.51%
1yr-24.93%
Volume Change (%)
10d/3m-78.38%
Price vs... (%)
52w High-41.86%
50d MA-11.55%
200d MA-9.02%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-96.27%
Return on Equity-88.64%
Operating Margin-81.07%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m9,616.499,815.3111,840.1710,631.5810,471.95n/an/a7.09%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of ADBiotech Co EPS forecast chart

Profile Summary

ADBiotech Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of veterinary drugs. The Company operates its business through two segments. Veterinary Medicine segment is engaged in the manufacture and sale of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, synthetic antibacterial agents and others. The Supplementary Feed segment is engaged in the manufacture and sale of functional supplementary feeds and other products.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    September 30th, 2024
    Incorporated
    June 20th, 2000
    Public Since
    December 24th, 2019
    No. of Shareholders
    6,815
    No. of Employees
    57
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    9,140,444

    179530 Share Price Performance

    Upcoming Events for 179530

    ADBiotech Co Ltd Annual Shareholders Meeting

    Similar to 179530

    Picture of AbClon logo

    AbClon

    kr flag iconKorea Exchange - KOSDAQ

    Picture of AHN-GOOK PHARMACEUTICAL Co logo

    AHN-GOOK PHARMACEUTICAL Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Alteogen logo

    Alteogen

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aminologics Co logo

    Aminologics Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Anterogen Co logo

    Anterogen Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ